UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934
Thermo Fisher Scientific Inc.
(Exact name of registrant as specified in its charter)
Delaware | 04-2209186 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
168 Third Avenue Waltham, Massachusetts | 02451 | |
(Address of principal executive offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be so registered | Name of each exchange on which | |
1.750% Senior Notes due 2027 | New York Stock Exchange LLC | |
2.375% Senior Notes due 2032 | New York Stock Exchange LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement or Regulation A offering statement file number to which this form relates (if applicable):
333-229951
Securities to be registered pursuant to Section 12(g) of the Act:
None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Thermo Fisher Scientific Inc. (the “Registrant”) has filed with the Securities and Exchange Commission (the “Commission”) pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act”), a prospectus supplement, dated March 30, 2020 (the “Prospectus Supplement”), and the accompanying prospectus, dated February 28, 2019 (the “Base Prospectus”). The Prospectus Supplement relates to the offering of €600,000,000 aggregate principal amount of 1.750% Senior Notes due 2027 and €600,000,000 aggregate principal amount of 2.375% Senior Notes due 2032 (collectively, the “Notes”) to be issued by the Registrant.
Item 1. Description of Registrant’s Securities to be Registered.
The descriptions under the heading “Description of the Notes” in the Prospectus Supplement and “Description of Thermo Fisher Debt Securities” in the Base Prospectus are incorporated by reference herein. Copies of such descriptions will be filed with The New York Stock Exchange.
Item 2. Exhibits.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934 the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
THERMO FISHER SCIENTIFIC INC. | ||||
Date: April 2, 2020 | By: | /s/ Michael A. Boxer | ||
Name: Michael A. Boxer Title: Senior Vice President and General Counsel |